Press release
Small-Molecule Injectable Market
The global Small-Molecule Injectable Market was valued at US$ 55.8 Bn in 2020. Expanding at a 7.3% CAGR, the market valuation is expected to top US$ 112.9 Bn by 2031, finds ESOMAR-certified consulting firm Future Market Insights (FMI) in a recent market analysis.The COVID-19 pandemic outbreak has sparked efforts to repurpose already-approved medicines for treatment. Several clinical studies are now being conducted on different antiviral medicines and small-molecule injectables that have been utilized in the past to treat diseases including SARS, MERS, HIV/AIDS, and malaria. For instance, Remdesivir was approved by FDA for the treatment of COVID-19 in hospitalized adult and pediatric patients.
This is expected to fuel sales of small-molecule injectables over the forecast period. Besides this, rising prevalence of chronic illnesses especially cancer and cardiovascular diseases across the globe are anticipated to usher developments in the small-molecule injectables market.
Pharmaceutical companies are aiming at production facility expansions to reduce corporate tax rate (in the U.S.), and to expand their footprints in emerging markets such as India and China, where production cost is low as compared to regions such as Europe and North America.
Recent tax reforms in the U.S., which include reduction of the corporate tax rate, have encouraged various large pharmaceutical and biopharmaceutical companies to invest in production facilities.
Request For Report Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14117
For example, in July 2020, Pfizer announced its plan to invest around US$ 465.0 million to build a sterile injectable plant in Portage, Michigan. This step is a part of its announcement that it made earlier in 2020 about its plans to invest around US$ 5.0 billion in a U.S.-based capital project due to the recent corporate tax reforms in the country. These developments are indicative of lucrative growth prospects for small-molecule injectable market players.
“Increasing adoption of chemotherapy for cancer treatment is expected to propel the small-molecule injectable market growth. In addition to this, fast track drug approvals will continue spurring demand for small-molecule injectables over the forecast period,” says the FMI Analyst.
Key Takeaways:
By product, the analgesics segment is expected to hold 23.9% of the total small-molecule injectable market in 2021, expanding at 8.0% CAGR.
In terms of applications, demand for small-molecule injectables in the infectious disease segment is expected to hold 31.7% of the total market share in 2021.
By route of administration, the intravenous segment is anticipated to hold 50% of the total market share in 2021.
Sales of small-molecule injectables through hospital pharmacies are projected to account for 67.8% of the total market share in 2021.
The U.S. is anticipated to dominate the North America small-molecule injectables market, holding 92.4% of the market share.
Germany is expected to hold of 21.9% of the Europe small-molecule injectable market share by 2031.
Small-molecule injectable market in China is projected to expand at a 9.0% CAGR over the forecast period.
Demand for small-molecule injectables in India is forecast to grow at an impressive 11.1% CAGR through 2031.
Sales of small-molecule injectables in South Korea and Japan are anticipated to rise at 5.0% and 8.8% respectively.
Any Questions about Report, ask us @ https://www.futuremarketinsights.com/ask-question/rep-gb-14117
Competition Landscape
The key market players covered by FMI include Aurobindo Pharma Limited, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., AstraZeneca Plc, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Novartis AG, Baxter International, Fresenius Kabi, Cipla Ltd, Mylan N.V., Sanofi S.A, and Dr. Reddy’s Laboratories Ltd.
Leading manufacturers of small-molecule injectables are focusing on strategic collaborations and partnerships to strengthen product portfolios. Manufacturers are also aiming at production facility expansions through acquisitions and mergers to gain a competitive edge in the market. For instance:
In September 2020, Aurobindo Pharma USA Inc. acquired commercial operations and three manufacturing facilities in the U.S from Sandoz Inc., USA, and Novartis Division.
In May 2020, Novartis AG received FDA approval for first Piqray - the first and only treatment specifically for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer.
In April 2020, AstraZeneca announced a collaboration with Benevolent AI to use machine learning and artificial intelligence to discover potential new drugs for chronic kidney disease and idiopathic pulmonary fibrosis.
More Insights into the Small-Molecule Injectable Market Report
Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global small-molecule injectable market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights into small-molecule injectable market. The market is segmented into five parts based on product (small molecule antibiotics, chemotherapy agents, local and general anesthetics, skeletal muscle relaxants, analgesics, anticoagulants, anticonvulsants, antivirals, anti-histamines/ anti-allergy, and others), application (oncology, pain management, cardiovascular diseases, infectious diseases, CNS diseases, blood disorders, musculoskeletal disorders, and others), route of administration (intravenous (IV), intramuscular (IM), and subcutaneous (SC)) and distribution channel (hospital pharmacies, retail pharmacies, drug stores, and mail order pharmacies) across seven major regions.
Buy Industry Research Report @ https://www.futuremarketinsights.com/checkout/14117
Contact
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
About FMI
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Small-Molecule Injectable Market here
News-ID: 2489586 • Views: …
More Releases from Future Market Insights
Global Pectin Market Poised for Steady Growth as Innovation, Sustainability, and …
The global pectin market is entering a dynamic growth phase, with its valuation projected to rise from USD 1,125.9 million in 2025 to USD 2,074.2 million by 2035, advancing at a CAGR of 6.3%. Unlike many markets driven by broad consumer preferences, the pectin industry's trajectory is fueled by technological advancements, targeted product development, and a rising demand for sustainable and natural solutions. Both established manufacturers and emerging players are…
Isomalto-oligosaccharide Market Poised for Growth as Health-Conscious Consumers …
The global Isomalto-oligosaccharide (IMO) market is entering a period of strong growth, fueled by changing dietary preferences, rising health awareness, and a surge in innovation among manufacturers. Valued at USD 86.8 million in 2025, the market is projected to nearly double, reaching USD 181.6 million by 2035 at a steady CAGR of 7.7%.
The momentum reflects a growing consumer shift toward healthier lifestyles, particularly as awareness around obesity, diabetes, and gut…
Ashwagandha Extract Market Set for Strong Growth, Driven by Health Awareness, Sc …
The global Ashwagandha Extract market is on a dynamic growth path, projected to rise from USD 815.7 million in 2025 to USD 1,787.2 million by 2035, achieving a CAGR of 8.2% over the forecast period. This momentum reflects a powerful convergence of consumer health awareness, scientific validation of Ashwagandha's benefits, and manufacturers-both established leaders and emerging players-introducing innovative formulations to capture growing demand.
The surge in demand comes at a time…
Taurine Market to Reach USD 954.8 Million by 2035, Backed by Expanding Use in He …
The global taurine market is on track for robust growth over the next decade, with demand rising from USD 476.4 million in 2025 to USD 954.8 million by 2035, representing a healthy CAGR of 7.2%. This expansion is fueled by taurine's growing role across health supplements, infant nutrition, functional foods, energy beverages, and pet health products.
Taurine, an amino acid long recognized for its cardiovascular, metabolic, and neurological benefits, is increasingly…
More Releases for FMI
Guidewires Market's Journey Ahead: FMI Report Anticipates 6.1% CAGR, US$ 5.9 Bil …
From 2022 to 2030, the global Guidewires Market is projected to develop significantly at a compound annual growth rate of 6.1%, with a market size of over US$ 3.7 Bn in 2022. The market is expanding at a faster rate due to rising demand for straight-tip guidewires for minimally invasive spine and cervical surgeries.
According to a new research study by Future Market Insights,
-Straight tip guidewires, with a current share of…
Ammonium Phosphate Market Share, Size, Trends - 2029 | FMI
The projected growth rate of ammonium phosphate market is approximately 3.3% over the course of forecast period (2019-2029). The demand from fertilizers segment remains steady and even surges in emerging economies. Other end-use industries such as electronics and optics are complementing the growth of ammonium phosphate market.
Download Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1469
Key Takeaways of Ammonium Phosphate Market Study
• Fertilizers industry accounts for substantial ammonium phosphate demand.
• Rising uptake of ammonium phosphate in…
Wearable Fitness Trackers Market Forecast & Share 2027 | FMI
The global wearable computing devices market is expected to be worth US$ 37,557 Mn in 2022, rising to US$ 217,237.2 Mn by 2032. The sales of wearable computing devices are expected to grow at a CAGR of 19.2% during 2022-2032.
The wearable computing devices market size is expected to increase during the projected period as they assist clinicians in remotely monitoring patient health. Consumer interest in smart fitness gadgets is increasing…
Edible Oil Packaging Market Size & Share - 2023 - 2031 | FMI
According to a recent report by Future Market Insight, sales of packaging solutions for edible oil would increase by 1.7 times to reach 3.7 billion units in 2031. In 2021, the market for packaging edible oil is anticipated to expand annually by 4.1%. By 2025, FMI projects that sales of drums will be close to $5 billion. The market for edible oil packaging in the United States is anticipated to…
MOPP Packaging Films Market Size, Analysis & Opportunity | FMI
The MOPP packaging films market is projected to register high demand through 2021, with the overall valuation reaching US$ 221.7 Mn in 2021. FMI also forecasts MOPP packaging films demand to increase at a steady 5.2% CAGR between 2021 and 2031.
Despite restrictions imposed amid COVID-19, MOPP packaging films demand will surge 2021 onwards, albeit gradually. Volume sold globally is expected to total 135.2 Th. tones by the end of…
Labels Market Size, Industry Share, Sales & Trends - 2032 | FMI
The global labels market size is set to reach a valuation of US$ 39.8 Bn in 2022, and further accelerate at a CAGR of 4.8% from 2022-2032. The market is projected to reach US$ 63.7 Bn by the end of 2032. Sales of labels are anticipated to augment with the top 5 players holding 10-15% of the global labels market share in 2021.
Based on product type, the pressure sensitive labels…
